Rufloxacin Once Daily Versus Ciprofloxacin Twice Daily in the Treatment of Patients with Acute Uncomplicated Pyelonephritis
- 1 July 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 154 (1) , 19-24
- https://doi.org/10.1016/s0022-5347(01)67213-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infectionsInfection, 1993
- Evaluation of New Anti-Infective Drugs for the Treatment of Urinary Tract InfectionClinical Infectious Diseases, 1992
- Diagnosis and Drug Treatment of Acute PyelonephritisDrugs, 1992
- The in-vitro activity of two new quinolones: rufloxacin and MF 961Journal of Antimicrobial Chemotherapy, 1992
- French consensus on antibiotherapy of urinary tract infectionsInfection, 1992
- An open multicentre study on the efficacy and safety of rufloxacin in patients with chronic bacterial prostatitisJournal of Antimicrobial Chemotherapy, 1991
- Side-effects of quinolones: Comparisons between quinolones and other antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Pharmacokinetics of Rufloxacin in Healthy Volunteers after Repeated Oral DosesChemotherapy, 1991
- In vitro Activity of a New Quinolone, Rufloxacin, against Nosocomial IsolatesChemotherapy, 1991
- Interpretation and Comparison of Treatment Studies for Uncomplicated Urinary Tract Infections in WomenClinical Infectious Diseases, 1985